GC
XENT

Guggenheim Capital’s Intersect ENT, Inc XENT Stock Holding History

Guggenheim Capital’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-39,091
Closed -$1.09M – 2182
2022
Q1 		$1.09M Buy
39,091
+435
+1% +$11.9K 0.01% 1320
2021
Q4 		$1.06M Buy
38,656
+471
+1% +$12.8K 0.01% 1351
2021
Q3 		$1.04M Buy
+38,185
New +$944K 0.01% 1395

Guggenheim Capital's XENT Position: Q2 2022 in Review

Guggenheim Capital sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 39,091 shares — an estimated $1.09M sold.

Guggenheim Capital first reported a position in XENT in Q3 2021 and held it in 3 quarters. The position peaked at $1.09M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.

  • Guggenheim Capital reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
  • Guggenheim Capital sold 39,091 Intersect ENT, Inc shares in Q2 2022, an estimated $1.09M.
  • Guggenheim Capital first reported a position in Intersect ENT, Inc in Q3 2021 and held it in 3 quarters.
  • Guggenheim Capital's Intersect ENT, Inc position peaked at $1.09M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.

Based on Guggenheim Capital's 13F filing for Q2 2022, filed 15 Aug 2022.